English
Factory Supply Imatinib - Molnupiravir (EIDD-2801) CAS 2349386-89-4 COVID-19 API High Quality – Ruifu Featured Image
  • Factory Supply Imatinib - Molnupiravir (EIDD-2801) CAS 2349386-89-4 COVID-19 API High Quality – Ruifu

Factory Supply Imatinib - Molnupiravir (EIDD-2801) CAS 2349386-89-4 COVID-19 API High Quality – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

We have now our possess revenue group, design staff, technical crew, QC team and package group. We now have strict excellent regulate procedures for each process. Also, all of our workers are experienced in printing subject for (R)-(-)-α-Methoxyphenylacetic Acid CAS 3966-32-3, (S)-Tetrahydrofuran-3-ol, 15231-91-1, As an experienced group we also accept customized orders. The main goal of our company is to build up a satisfying memory for all customers, and establish a long-term win-win business relationship.
Factory Supply Imatinib - Molnupiravir (EIDD-2801) CAS 2349386-89-4 COVID-19 API High Quality – Ruifu Detail:

Manufacturer Commercial Supply Remdesivir and Related Intermediates with High Quality

Chemical Name Molnupiravir (EIDD-2801)
Synonyms MK-4482; β-D-N4-Hydroxycytidine-5′-isopropyl ester; ((2R,3S,4R,5R)-3,4-dihydroxy-5-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate
CAS Number 2349386-89-4, 2492423-29-5
CAT Number RF-API97
Stock Status In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula C13H19N3O7
Molecular Weight 329.31
Solubility Soluble in DMSO
Brand Ruifu Chemical
Item Specifications
Appearance White to Off-White Powder
Identification IR Sample Spectrum corresponds to that of reference standard
Identification HPLC The retention time of the major peak of the sample solution corresponds to that of the standard solution
Related Substances
20H01 ≤0.10%
20H02 ≤0.10%
20H04 ≤0.10%
20HIb ≤0.10%
20H21 ≤0.10%
Any Unspecified Impurity ≤0.10%
Total Unspecified Impurities ≤0.30%
Total Impurities ≤0.50%
Residual Solvents
N-Heptane ≤5000ppm
Ethanol ≤5000ppm
Isopropyl Acetate ≤5000ppm
Acetonitrile ≤410ppm
Methylene Dichloride ≤600ppm
Acetone ≤5000ppm
Isopropanol ≤5000ppm
Water Content (K.F) ≤0.50%
Loss on Drying ≤1.0%
Residue on Ignition ≤0.10%
Optical Rotation -7.5° to -9.5° (C=0.5, Methanol)
Heavy Metals ≤10ppm
Purity / Analysis Method ≥99.5% (230nm)
Assay / Analysis Method 98.0%~102.0% (HPLC on dried basis)
Shelf Life 24 Months
Test Standard Enterprise Standard
Usage API, Molnupiravir (EIDD-2801) COVID-19 Inhibitor

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

1

Molnupiravir (EIDD-2801, MK-4482) is an orally bioavailable prodrug of the ribonucleoside analog β-d-N4-hydroxycytidine (NHC; EIDD-1931) with broad-spectrum antiviral activity against SARS-CoV-2, MERS-CoV, SARS-CoV, and the causative agent of COVID-19. Molnupiravir is sold under the brand name Lagevrio and generically as emorivir. Molnupiravir has been shown to improve pulmonary function, decrease body weight loss and reduce the amount of virus in the lung. In addition to activity against coronaviruses, Molnupiravir, in laboratory studies, has demonstrated activity against seasonal and bird influenza, respiratory syncytial virus, chikungunya virus, Ebola virus, Venezuelan equine encephalitis virus, and Eastern equine encephalitis virus. Molnupiravir was originally developed to treat influenza at Emory University by the university’s drug innovation company, Drug Innovation Ventures at Emory (DRIVE), but was reportedly abandoned for mutagenicity concerns. It was then acquired by Miami-based company Ridgeback Biotherapeutics, which later partnered with Merck & Co. to develop the drug further. Molnupiravir was approved for medical use in the United Kingdom in November 2021.

Product detail pictures:

Factory Supply Imatinib - Molnupiravir (EIDD-2801) CAS 2349386-89-4 COVID-19 API High Quality – Ruifu detail pictures

Related Product Guide:
We emphasize progress and introduce new solutions into the market each year for Factory Supply Imatinib - Molnupiravir (EIDD-2801) CAS 2349386-89-4 COVID-19 API High Quality – Ruifu , The product will supply to all over the world, such as: Ethiopia, Qatar, Bahrain, We solution have passed through the national skilled certification and been well received in our key industry. Our specialist engineering team will often be ready to serve you for consultation and feedback. We are able to also provide you with no cost samples to meet your needs. Best efforts will be produced to offer you the very best service and solutions. For anyone who is considering our business and solutions, please speak to us by sending us emails or get in touch with us right away. As a way to know our products and enterprise. lot more, you'll be able to come to our factory to find out it. We will constantly welcome guests from around the globe to our firm. o build enterprise. elations with us. Please really feel absolutely free to make contact with us for small business and we believe we will share the top trading practical experience with all our merchants.
    • The sales manager is very patient, we communicated about three days before we decided to cooperate, finally, we are very satisfied with this cooperation!
    5 Stars By Karen from Burundi - 2017.08.16 13:39
    The accounts manager made a detailed introduction about the product, so that we have a comprehensive understanding of the product, and ultimately we decided to cooperate.
    5 Stars By Mag from Mali - 2017.05.21 12:31
    Write your message here and send it to us